Hippotherapy Simulator in Children With Cerebral Palsy

Marmara University

Status: Completed

Conditions: Cerebral Palsy, Spastic; Rehabilitation

Treatments: Device: Hippotherapy Simulator; Other: Neurodevelopmental Therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT04378036

MarHippos

Details and patient eligibility

About

The aim of this study was to research the effects of hippotherapy simulator in children with Cerebral Palsy. In order to evaluate its effectiveness, assessment of gross motor functions, lower extremity functions, muscle tone and spasticity, trunk control, sitting and standing balance, walking functions and functional independence were being applied.

Full description

"Cerebral Palsy (CP) describes a group of permanent disorders of the development of movement and posture, causing activity limitation, that is attributed to nonprogressive disturbances that occurred in the developing fetal or infant brain." The motor disorders of CP are often accompanied by disturbances of sensation, perception, cognition, communication, and behavior, by epilepsy, and by secondary musculoskeletal problems.

CP is the most common neurodevelopmental disorder that begins in early childhood, continues for life and causes physical impairment. Damage occurring in the developing brain results in voluntary movement, postural and motor control disorders, balance problems and gait disorders.

Hippotherapy is used effectively in increasing the participation of children with CP by improving their balance, motor function, posture and mobility and improving their quality of life. Although hippotherapy has many physical, functional, emotional and social benefits for children with CP, it also has some disadvantages that limit its use in the treatment of these children. There are risks such as serious injuries caused by children being afraid of a horse, falling from a horse or kicking a horse, increased hypertonicity due to fear and stress on the horse and exposure to allergic reactions due to environmental antigens. In order to overcome these conditions and reach more patients, hippotherapy simulator systems, which have been increasing rapidly in recent years, have been developed.

Hippotherapy simulators are systems that mimic the walking and movements of a real horse. As they are a newly developed system, studies investigating their effectiveness, especially in children with CP, are very limited. The aim of this study is to research the effects of hippotherapy simulator on gross motor functions, lower extremity functions, muscle tone and spasticity, trunk control, sitting and standing balance, walking functions and functional independence in children with Cerebral Palsy.

Enrollment: 30 patients

Sex: All

Ages: 5 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Having a diagnosis of Spastic Cerebral Palsy
• Children aged between 5 - 18 years
• GMFCS level is I, II or III
• Independent seating
• Walking with at least 10 meters of independent, orthotic and/or auxiliary device
• Can understand simple verbal instruction
• Those with hip adductor muscle spasticity level less than 2 according to MAS
• Having bilateral passive hip abduction enough to could sit into the hippotherapy simulator device
• Voluntarily agreed to participate in the study

Exclusion criteria

• Those with hip dislocation
• Severe contracture or deformity to prevent the study
• Advanced scoliosis (above 20 degrees)
• Acute uncontrolled acute seizures
• Uncontrollable severe epileptic attacks
• Visual and auditory problems
• Injection of botulinum toxin in the last 6 months patients
• Underwent surgical operation such as muscle relaxation, tendon extension, and selective dorsal rhizotomy in the last 6 months

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

30 participants in 2 patient groups

Neurodevelopmental Therapy Group

Active Comparator group

Description:

The number of participants in this group is 30. All participants were included in the rehabilitation program using only the Neurodevelopmental Therapy approach for 16 sessions (8 weeks x 2 days x 45 minutes).

Treatment:

Other: Neurodevelopmental Therapy

Hippotherapy Simulator Group

Active Comparator group

Description:

The same participants were taken into a rehabilitation program in which 16 sessions (8 weeks x 2 days a week) the Hippotherapy Simulator device (30 minutes) and Neurodevelopmental Therapy (NDT) (15 minutes) (HS + NDT method) were used together.

Treatment:

Device: Hippotherapy Simulator

Other: Neurodevelopmental Therapy